Pharmatrophix, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Pharmatrophix, Inc.
Quantité totale PI 22
Rang # Quantité totale PI 68 504
Note d'activité PI 1,4/5.0    5
Rang # Activité PI 197 989

Brevets

Marques

11 0
2 0
9 0
0
 
Dernier brevet 2024 - Methods and compositions for tre...
Premier brevet 2010 - Crystalline forms of neurotrophi...

Derniers inventions, produits et services

2023 Invention Methods and compositions for treating and managing alzheimer's disease. The disclosure provides ...
2022 Invention Methods and compositions for treating and managing alzheimer's disease. The disclosure provides c...
2021 Invention Crystalline forms of neurotrophin mimetic compounds and their salts. The present invention inclu...
Invention Compositions and methods for treating and preventing cognitive dysfunction. Provided are composi...
2020 Invention Compositions and methods for treating and preventing cognitive dysfunction. Provided are composit...
2019 Invention Crystalline forms of neurotrophin mimetic compounds and their salts. The present invention includ...
2017 Invention Methods and compounds for treating alcohol use disorders and associated diseases. Methods and com...
2014 Invention Deuterated compounds useful for treating neurodegenerative diseases. The present application is r...
Invention Non-peptide bdnf neurotrophin mimetics. Methods and compounds for treating neurological and othe...
Invention Non-peptide bdnf neurotrophin mimetics. Methods and compounds for treating neurological and other...
2010 Invention Deuterated compounds useful for treating neurodegenerative diseases. The present application is ...